Literature DB >> 3003157

Identification of the thrombin receptor on human platelets by chemical crosslinking.

J Takamatsu, M K Horne, H R Gralnick.   

Abstract

To identify the molecular site of thrombin binding to the platelet membrane, we covalently linked 125I-thrombin to platelets by using the bifunctional chemical cross-linking agents disuccinimidyl suberate and dithiobis(succinimidyl propionate). The proteins cross-linked to 125I-thrombin by this method were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and followed by autoradiography. Two radiolabeled thrombin complexes were identified, a major species of Mr approximately 200,000 and a minor one of Mr approximately 400,000. Hirudin prevented the formation of both complexes. The radioactivity of the approximately 200,000-Mr complex was always 7-10-fold greater than the radioactivity of the approximately 400,000-Mr complex regardless of the thrombin concentration to which the platelets were exposed (0.1-29 nM). Although 125I-thrombin complexes generated with thrombasthenic platelets (lacking glycoprotein IIb/IIIa) were indistinguishable from normal, no complexes appeared when Bernard-Soulier platelets (lacking glycoprotein Ib [GPIb]) were used. Complex formation was blocked by rabbit antiglycocalicin antiserum, but not by the monoclonal antibody 6D1, which is directed against the site on GPIb where von Willebrand factor (vWf) binds in the presence of ristocetin. Although cross-linking studies suggested that vWf might partially inhibit thrombin binding to platelets, this was not confirmed by equilibrium binding studies in the presence of vWf and ristocetin. The data suggest, therefore, that at all thrombin concentrations binding occurs at the same membrane site, despite evidence from equilibrium studies for high and low affinity classes of receptors, and that the approximately 400,000-Mr complex is simply a dimer of the approximately 200,000-Mr species. We conclude that the membrane site to which thrombin binds is the glycocalicin portion of platelet GPIb at a site remote from the point of ristocetin-dependent vWf binding.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003157      PMCID: PMC423355          DOI: 10.1172/JCI112313

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

2.  Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface.

Authors:  T Okumura; M Hasitz; G A Jamieson
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

3.  A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

4.  Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing.

Authors:  S W Tam; J W Fenton; T C Detwiler
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

5.  Receptor aggregation: a possible mechanism of platelet stimulation by thrombin.

Authors:  P Ganguly; N L Gould
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

6.  Immunoinhibition of ristocetin-induced platelet aggregation.

Authors:  R L Nachman; E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Reduced thrombin binding and aggregation in Bernard-Soulier platelets.

Authors:  G A Jamieson; T Okumura
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Thrombin binding to thrombasthenic platelets.

Authors:  G C White; E F Workman; R L Lundblad
Journal:  J Lab Clin Med       Date:  1978-01

9.  Thrombin receptors of human platelets: thrombin binding and antithrombin properties of glycoprotein I.

Authors:  P Ganguly; N L Gould
Journal:  Br J Haematol       Date:  1979-05       Impact factor: 6.998

10.  Preparation and application of a photoreactive thrombin analogue: binding to human platelets.

Authors:  N E Larsen; E R Simons
Journal:  Biochemistry       Date:  1981-07-07       Impact factor: 3.162

View more
  5 in total

1.  Stimulation of polyphosphoinositide hydrolysis by thrombin in membranes from human fibroblasts.

Authors:  M J Rebecchi; O M Rosen
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

2.  Platelet storage results in a redistribution of glycoprotein Ib molecules. Evidence for a large intraplatelet pool of glycoprotein Ib.

Authors:  A D Michelson; B Adelman; M R Barnard; E Carroll; R I Handin
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

3.  The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.

Authors:  Wolfgang Bergmeier; Crystal L Piffath; Tobias Goerge; Stephen M Cifuni; Zaverio M Ruggeri; Jerry Ware; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

4.  4,4'-Di-isothiocyanatostilbene-2,2'-disulphonic acid ('DIDS') activates protein kinase C and Na+/H+ exchange in human platelets via alpha 2A-adrenergic receptors.

Authors:  R Nieuwland; G Van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

5.  High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: identification of two binding domains.

Authors:  H R Gralnick; S Williams; L P McKeown; K Hansmann; J W Fenton; H Krutzsch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.